Novo Nordisk reported DKK45.65B in Stock for its fiscal quarter ending in June of 2025.





Stock Change Date
Bausch Health Companies USD 1.59B 11M Sep/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
Merck USD 6.16B 43M Sep/2026
Novartis USD 6.1B 116M Sep/2026
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Novo Nordisk DKK 51.35B 8.5B Mar/2026
Pacira USD 3.83B 3.69B Sep/2026
Sanofi EUR 24.12B 620M Jun/2026
Supernus Pharmaceuticals USD 113.24M 6.22M Sep/2026